MARK C. BENYUNES

Person

San Francisco, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Adjuvant treatment of HER2-positive breast cancer
- Patent number 12,128,103
- Issue date Oct 29, 2024
- Genentech, Inc.
- Mark C. Benyunes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Adjuvant treatment of HER2-positive breast cancer
- Patent number 11,992,529
- Issue date May 28, 2024
- Genentech, Inc.
- Mark C. Benyunes
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Adjuvant treatment of HER2-positive breast cancer
- Patent number 11,638,756
- Issue date May 2, 2023
- Genentech, Inc.
- Mark C. Benyunes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Adjuvant treatment of HER2-positive breast cancer
- Patent number 11,077,189
- Issue date Aug 3, 2021
- Genentech Inc.
- Mark C. Benyunes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Therapy of autoimmune disease in a patient with an inadequate respo...
- Patent number 7,976,838
- Issue date Jul 12, 2011
- Genentech, Inc.
- Mark C. Benyunes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Therapy of autoimmune disease in a patient with an inadequate respo...
- Patent number 7,708,994
- Issue date May 4, 2010
- Genentech, Inc.
- Mark C. Benyunes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
ADJUVANT TREATMENT OF HER2-POSITIVE BREAST CANCER
- Publication number 20250018032
- Publication date Jan 16, 2025
- Genentech, Inc.
- Mark C. BENYUNES
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ADJUVANT TREATMENT OF HER2-POSITIVE BREAST CANCER
- Publication number 20240252634
- Publication date Aug 1, 2024
- Genentech, Inc.
- Mark C. BENYUNES
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ADJUVANT TREATMENT OF HER2-POSITIVE BREAST CANCER
- Publication number 20230000977
- Publication date Jan 5, 2023
- Genentech, Inc.
- Mark C. BENYUNES
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USES FOR AND ARTICLE OF MANUFACTURE INCLUDING HER2 DIMERIZATION INH...
- Publication number 20220362379
- Publication date Nov 17, 2022
- Genentech, Inc.
- Mark C. Benyunes
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ADJUVANT TREATMENT OF HER2-POSITIVE BREAST CANCER
- Publication number 20210330789
- Publication date Oct 28, 2021
- Genentech, Inc.
- Mark C. BENYUNES
- C07 - ORGANIC CHEMISTRY
Information Patent Application
USES FOR AND ARTICLE OF MANUFACTURE INCLUDING HER2 DIMERIZATION INH...
- Publication number 20210015919
- Publication date Jan 21, 2021
- Genentech, Inc.
- Mark C. Benyunes
- C07 - ORGANIC CHEMISTRY
Information Patent Application
USES FOR AND ARTICLE OF MANUFACTURE INCLUDING HER2 DIMERIZATION INH...
- Publication number 20200376120
- Publication date Dec 3, 2020
- Genentech, Inc.
- Mark C. Benyunes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USES FOR AND ARTICLE OF MANUFACTURE INCLUDING HER2 DIMERIZATION INH...
- Publication number 20200206348
- Publication date Jul 2, 2020
- Genentech, Inc.
- Mark C. Benyunes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USES FOR AND ARTICLE OF MANUFACTURE INCLUDING HER2 DIMERIZATION INH...
- Publication number 20190117769
- Publication date Apr 25, 2019
- Genentech, Inc.
- Mark C. Benyunes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ADJUVANT TREATMENT OF HER2-POSITIVE BREAST CANCER
- Publication number 20180250397
- Publication date Sep 6, 2018
- Genentech, Inc.
- Mark C. BENYUNES
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USES FOR AND ARTICLE OF MANUFACTURE INCLUDING HER2 DIMERIZATION INH...
- Publication number 20160175438
- Publication date Jun 23, 2016
- Genentech, Inc.
- Sreedhara Alavattam
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USES FOR AND ARTICLE OF MANUFACTURE INCLUDING HER2 DIMERIZATION INH...
- Publication number 20130095172
- Publication date Apr 18, 2013
- Genentech, Inc.
- Sreedhara Alavattam
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
THERAPY OF AUTOIMMUNE DISEASE IN A PATIENT WITH AN INADEQUATE RESPO...
- Publication number 20110300136
- Publication date Dec 8, 2011
- Genentech, Inc.
- MARK C. BENYUNES
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Apo-2L receptor agonist and CPT-11 synergism
- Publication number 20090041788
- Publication date Feb 12, 2009
- Genentech, Inc.
- Avi J. Ashkenazi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
THERAPY OF AUTOIMMUNE DISEASE IN A PATIENT WITH AN INADEQUATE RESPO...
- Publication number 20080213280
- Publication date Sep 4, 2008
- Genentech, Inc.
- MARK C. BENYUNES
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
APO-2L receptor agonist and CPT-11 synergism
- Publication number 20070026000
- Publication date Feb 1, 2007
- Genentech, Inc.
- Avi J. Ashkenazi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Therapy of autoimmune disease in a patient with an inadequate respo...
- Publication number 20060240008
- Publication date Oct 26, 2006
- Genentech, Inc.
- Mark C. Benyunes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Apo-2L receptor agonist and CPT-11 synergism
- Publication number 20040228868
- Publication date Nov 18, 2004
- Genentech, Inc.
- Avi J. Ashkenazi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Therapy of autoimmune disease in a patient with an inadequate respo...
- Publication number 20040202658
- Publication date Oct 14, 2004
- Genentech, Inc.
- Mark C. Benyunes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

MARK C. BENYUNES

Person

Patents Grantslast 30 patents

Adjuvant treatment of HER2-positive breast cancer

Adjuvant treatment of HER2-positive breast cancer

Adjuvant treatment of HER2-positive breast cancer

Adjuvant treatment of HER2-positive breast cancer

Therapy of autoimmune disease in a patient with an inadequate respo...

Therapy of autoimmune disease in a patient with an inadequate respo...

Patents Applicationslast 30 patents

ADJUVANT TREATMENT OF HER2-POSITIVE BREAST CANCER

ADJUVANT TREATMENT OF HER2-POSITIVE BREAST CANCER

ADJUVANT TREATMENT OF HER2-POSITIVE BREAST CANCER

USES FOR AND ARTICLE OF MANUFACTURE INCLUDING HER2 DIMERIZATION INH...

ADJUVANT TREATMENT OF HER2-POSITIVE BREAST CANCER

USES FOR AND ARTICLE OF MANUFACTURE INCLUDING HER2 DIMERIZATION INH...

USES FOR AND ARTICLE OF MANUFACTURE INCLUDING HER2 DIMERIZATION INH...

USES FOR AND ARTICLE OF MANUFACTURE INCLUDING HER2 DIMERIZATION INH...

USES FOR AND ARTICLE OF MANUFACTURE INCLUDING HER2 DIMERIZATION INH...

ADJUVANT TREATMENT OF HER2-POSITIVE BREAST CANCER

USES FOR AND ARTICLE OF MANUFACTURE INCLUDING HER2 DIMERIZATION INH...

USES FOR AND ARTICLE OF MANUFACTURE INCLUDING HER2 DIMERIZATION INH...

THERAPY OF AUTOIMMUNE DISEASE IN A PATIENT WITH AN INADEQUATE RESPO...

Apo-2L receptor agonist and CPT-11 synergism

THERAPY OF AUTOIMMUNE DISEASE IN A PATIENT WITH AN INADEQUATE RESPO...

APO-2L receptor agonist and CPT-11 synergism

Therapy of autoimmune disease in a patient with an inadequate respo...

Apo-2L receptor agonist and CPT-11 synergism

Therapy of autoimmune disease in a patient with an inadequate respo...